Log in

OTCMKTS:BGMD - BG Medicine Stock Price, Forecast & News

$0.03
+0.01 (+25.45 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$0.02
Now: $0.03
$0.03
50-Day Range
$0.02
MA: $0.02
$0.05
52-Week Range
$0.01
Now: $0.03
$0.05
Volume2,490 shs
Average Volume18,910 shs
Market Capitalization$313,812.00
P/E RatioN/A
Dividend YieldN/A
Beta1.93
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.
Read More
BG Medicine logo

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryLife Sciences Tools & Services
SectorMedical
Current SymbolOTCMKTS:BGMD
Previous SymbolNASDAQ:BGMD
CUSIP08861T10
Phone781-890-1199

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees5
Market Cap$313,812.00
Next Earnings DateN/A
OptionableNot Optionable

Receive BGMD News and Ratings via Email

Sign-up to receive the latest news and ratings for BGMD and its competitors with MarketBeat's FREE daily newsletter.


BG Medicine (OTCMKTS:BGMD) Frequently Asked Questions

How has BG Medicine's stock been impacted by COVID-19 (Coronavirus)?

BG Medicine's stock was trading at $0.0151 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BGMD shares have increased by 82.8% and is now trading at $0.0276. View which stocks have been mosted impacted by Coronavirus.

How were BG Medicine's earnings last quarter?

BG Medicine, Inc. (OTCMKTS:BGMD) issued its quarterly earnings data on Tuesday, November, 17th. The medical research company reported ($0.27) EPS for the quarter. The medical research company had revenue of $334 million for the quarter, compared to the consensus estimate of $695 million. View BG Medicine's earnings history.

Has BG Medicine been receiving favorable news coverage?

Press coverage about BGMD stock has been trending somewhat negative recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. BG Medicine earned a daily sentiment score of -1.5 on InfoTrie's scale. They also assigned news articles about the medical research company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutBG Medicine.

Who are some of BG Medicine's key competitors?

What other stocks do shareholders of BG Medicine own?

Who are BG Medicine's key executives?

BG Medicine's management team includes the following people:
  • Dr. Paul R. Sohmer, CEO, Pres & Director (Age 70)
  • Mr. Stephen P. Hall, CFO, Exec. VP & Treasurer (Age 68)
  • Dr. Aram Adourian, Chief Scientific Officer (Age 49)

What is BG Medicine's stock symbol?

BG Medicine trades on the OTCMKTS under the ticker symbol "BGMD."

How do I buy shares of BG Medicine?

Shares of BGMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BG Medicine's stock price today?

One share of BGMD stock can currently be purchased for approximately $0.03.

How big of a company is BG Medicine?

BG Medicine has a market capitalization of $313,812.00. BG Medicine employs 5 workers across the globe. View additional information about BG Medicine.

What is BG Medicine's official website?

The official website for BG Medicine is http://www.bg-medicine.com/.

How can I contact BG Medicine?

BG Medicine's mailing address is 303 Wyman Street Suite 300, Waltham MA, 02451. The medical research company can be reached via phone at 781-890-1199 or via email at [email protected]


MarketBeat Community Rating for BG Medicine (OTCMKTS BGMD)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  91 (Thanks for Voting!)
Underperform Votes:  104 (Thanks for Voting!)
Total Votes:  195
MarketBeat's community ratings are surveys of what our community members think about BG Medicine and other stocks. Vote "Outperform" if you believe BGMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BGMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel